EUVIMEDEUVIMED entdecken
Crossref

In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling

Farhan Ullah, Abdus Samad, Shahid Ullah, Peter Chinedu Agu, Na Yang, Ming Lei, Liang Chen, Sheng Wang

Journal of Proteins and Proteomics · 21.03.2026 · 17 (2) · 131-145

DOI: 10.1007/s42485-026-00207-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteins and Proteomics, online erschienen am 21.03.2026. Verfasst von Farhan Ullah und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Training Program of the Major Research Plan of the National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Training Program of the Major Research Plan of the National Natural Science Foundation of China

Zitieren

APA

Ullah, F., Samad, A., Ullah, S., Agu, P. C., Yang, N., Lei, M., Chen, L., & Wang, S. (2026). In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling. Journal of Proteins and Proteomics, 17(2), 131-145. https://doi.org/10.1007/s42485-026-00207-0

Vancouver

Ullah F, Samad A, Ullah S, Agu PC, Yang N, Lei M, et al. In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling. Journal of Proteins and Proteomics. 2026;17(2):131-145. doi:10.1007/s42485-026-00207-0

BibTeX
@article{Ullah2026,
  author = {Ullah, Farhan and Samad, Abdus and Ullah, Shahid and Agu, Peter Chinedu and Yang, Na and Lei, Ming and Chen, Liang and Wang, Sheng},
  title = {In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling},
  journal = {Journal of Proteins and Proteomics},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {131--145},
  doi = {10.1007/s42485-026-00207-0}
}
Kostenlos starten →